Jorge Amaro, DPM
Foot & Ankle Surgery · Omaha, NENPI 1821245648
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (58.3%), food and beverage and education — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Stryker at 37.2% of the total. Reporting peaked in 2022 at $4,676 and has fallen 69.0% since, to $1,449 in 2025.
Across 98 payments — averaging $99.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$4K
- Treace Medical Concepts, Inc.$2K
- Zimmer Biomet$1K
- Conetic Solutions, Inc.$1K
- Smith+Nephew$474
- Orthofix Medical, Inc.$451
- plus $543 from 10 others
What the payments were for
- Travel & lodging$5,67358%
- Food & beverage$2,85629%
- Education$1,20012%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 15 | $3,618 |
| Treace Medical Concepts, Inc. | 12 | $1,970 |
| Zimmer Biomet | 14 | $1,415 |
| Conetic Solutions, Inc. | 3 | $1,259 |
| Smith+Nephew | 24 | $474 |
| Orthofix Medical, Inc. | 11 | $451 |
| Organogenesis Inc. | 1 | $124 |
| Integra Lifesciences Corporation | 4 | $86 |
| Kerecis Limited | 4 | $84 |
| Averitas Pharma Inc. | 3 | $64 |
| Orpyx Medical Technologies US Inc. | 1 | $53 |
| Innovation Technologies Inc | 2 | $43 |
| Wardlow Enterprises | 1 | $32 |
| Solventum Corporation | 1 | $20 |
| Pacira Pharmaceuticals Incorporated | 1 | $18 |
| Paratek Pharmaceuticals, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lapiplasty System$1,656
- PROstep$1,554
- Trabecular Metal (TM)$1,159
- ORTHOLOC 3DI$747
- HOFFMANN$650
- OMEGA$164
- ORTHOLOC 2 LAPIFUSE$145
- TrueLok$145
- PURAPLY WOUND MATRIX$124
- GRAFIX PL$107
- STRAVIX PL$107
How this compares
$9,729 in reported general payments places this provider in the 60th percentile of 43 foot & ankle surgery providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 14 | $569 |
| Gabapentin | 18 | $477 |
| Ammonium Lactate | 17 | $316 |
| Oxycodone Hcl | 11 | $132 |
| Meloxicam | 14 | $8 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Omaha
- Bradley CoppleOmaha$83K
- Robert GreenhagenOmaha$29K
- Patrick NelsonOmaha$28K
- Jonathan RouseOmaha$20K
- Scott NelsonOmaha$16K
- Jordan SikesOmaha$15K
- Shannon LensingOmaha$11K
- Kevin GrosshansOmaha$8K
- Kent DinucciOmaha$4K
- Reanen MichaelOmaha$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.